Hap Trading, LLC Relmada Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$18.3 - $37.02 $644,160 - $1.3 Million	35,200 Added 33.78%	139,400 $1.7 Million
Q2 2022 Aug 12, 2022	BUY	$16.5 - $30.34 $1.72 Million - $3.16 Million	104,200 New	104,200 $53,000
Q3 2021 Nov 10, 2021	SELL	$21.86 - $34.77 $880,958 - $1.4 Million	-40,300 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$29.55 - $39.15 $1.19 Million - $1.58 Million	40,300 New	40,300 $28,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $77.8M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.